Combioxin SA
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.combioxin.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
Phase 1
Completed
- Conditions
- PneumoniaPneumococcal Infections
- Interventions
- Drug: CAL02 Low-doseDrug: CAL02 High-doseDrug: Placebo
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Combioxin SA
- Target Recruit Count
- 19
- Registration Number
- NCT02583373
- Locations
- 🇧🇪
St Luc University Hospital, Brussels, Belgium
🇧🇪University Hospital Brussels, Brussels, Belgium
🇧🇪Clinique St Pierre, Ottignies, Belgium
News
No news found